CONSTANT THERAPEUTICS LLC
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Phase 2 Study of TXA127 in Post-ischemic Stroke Patients
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Constant Therapeutics LLC
- Target Recruit Count
- 50
- Registration Number
- NCT06135103
- Locations
- 🇮🇱
Sheba Medical Center, Ramat Gan, Israel
TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Constant Therapeutics LLC
- Target Recruit Count
- 10
- Registration Number
- NCT06013839
- Locations
- 🇮🇱
Hadassah Medical Center, Jerusalem, Israel
🇮🇱Sheba Medical Center, Ramat Gan, Israel
News
No news found